Yu Shyr received his PhD in biostatistics from the University of Michigan in 1994 and subsequently joined the faculty at Vanderbilt University School of Medicine. Dr. Shyr is an elected fellow of the American Statistical Association (ASA), the American Association for the Advancement of Science (AAAS), and the American Association for Cancer Research (AACR), and he holds an honorary doctorate from National Cheng Kung University. He has published more than 500 peer-reviewed papers (h-index = 117) and serves as an associate editor for JAMA Oncology and Journal of Thoracic Oncology. Dr. Shyr has presented more than 300 invited talks, workshops, and courses around the world.

Dr. Shyr was a voting member of the US Food and Drug Administration (FDA) Anti-Infective Drugs Advisory Committee and has served on dozens of National Cancer Institute (NCI) study sections and panels. As principal investigator of the Barrett’s Esophagus Translational Research Network Coordinating Center, funded by an NCI U24 grant, he led a team that provided crucial support for the collection, management, analysis, and dissemination of data among multiple research centers. His current projects include developing novel statistical and bioinformatic tools for biomedical research, particularly in the areas of proteomics and genomics, with special focus on single-cell RNA sequencing (scRNA-seq).

陳瑞杰董事長，現任臺北醫學大學講座教授。臺北醫學大學醫學士及醫學資訊研究所碩士。曾任臺北醫學大學附設醫院院長、臺北醫學大學管發中心主任、萬芳醫學中心副院長兼外科部主任、臺灣外傷醫學會理事長及臺灣外科醫學會常務理事。在醫學資訊與醫院管理上經驗豐富，長期致力於推動北醫大朝向智慧醫院的發展。

【現職】
- 醫聯網 創辦人
- 眾匯智能健康股份有限公司 董事長

從事預防醫學業近 30 年。近年致力於推動健康照護產業數位轉型，成立台灣第一個健康照護資源共享平台-醫聯網。以”讓科技改變健康照護模式”為企業使命，致力於提升人們自主健康管理能力，降低醫療資源浪費，並為健康照護產業開創新的契機。

【學歷】
- 國立台灣大學管理學院 商學碩士 (EMBA)
- 臺北醫學大學醫事技術學系 學士

【經歷】
- 哈佛健診 創辦人
- 社團法人台灣數位健康產業發展協會 副理事長
- 中華民國第 29 屆創業楷模 (2006)
- 經濟部中小企業發展基金 管理委員會委員
- 財團法人醫院評鑑暨醫療品質策進會 認證委員
- 社團法人瑪利亞社會福利基金會 董事
- 創業楷模聯誼會 會長
- 衛福部APEC會議專家諮詢委員會 委員
- 台大管理學院EMBA學生會 會長

【著作】
- 《有願景，更要堅持到底》 (2009 商周)
- 《健康力，就是競爭》 (2015 經濟)

【現職】
- 台灣數位健康大聯盟 共同召集人
- 鴻海科技集團 B事業群數位健康專案 執行長
- 疆域醫創 董事兼策略執行長

【重要經歷】
- 曾任Systex主任系統架構設計師
- Apple產品設計開發/大數據應用開發
- Master of Science in Computer Science, California Lutheran University

【專長】
醫療級健康裝置的設計研發與生產/Al與數據分析整合應用/精準場域情境式產品整合設計

張嘉淵博士(Ted Chang)為廣達電腦技術長暨副總經理 (CTO, VP＆GM)、廣達研究院(QRI)院長負責廣達前瞻產品研發、未來科技策略及全球研發合作。並帶領廣達BU12事業部，主導智慧物聯網 (AIoT)、智慧醫療及智慧農業等新事業。於2019年接受總統任命為亞太經濟合作企業資諮詢委員會(APEC Business Advisory Council, ABAC)之國家代表，並應邀擔任ABAC數位工作小組(Digital Working Group)共同主席(2022)，ABAC支持持新興科技任務小組共同召集人(2021)。

張博士於1996在國立成功大學航空太空工程研究所完成所有高等教育。現今的研究興趣在【軟硬整合之虛實應用】：結合雲端運算(Cloud Computing)、大數據分析(Big Data Analytics)、演算法(Algorithm Synthesis)、社群媒體。

【現職】
- 臺中榮民總醫院院長
- 國立中興大學副校長
- 國立陽明大學醫學系內科教授
- 美國凱斯西儲大學兼任教授

【經歷】
- 臺北榮民總醫院副院長
- 臺北榮民總醫院內科部主任
- 臺北榮民總醫院心臟內科主任
- 中華民國心律醫學會理事長
- 亞太心律醫學會理事長
- 亞太心律醫學會秘書長
- 台灣心律不整學術會會長
- 亞太心房顫動學術會會長

陳董事長所創辦的安盛生科，是行動醫療領域的先驅；安盛以賦能智慧化的健康管理為使命，除專注科技創新之外，亦透過策略合作積極拓展國際巿場，期能最大化對未來醫療的貢獻。而陳董事長於MIT、Caltech以及Stanford的歷練，亦厚實了他在先進技術研發與創新創業上的底蘊。他擁有台大電機博士學位，並於2019年獲頒艾森豪獎金，與美國近五十家醫療機構及生醫新創生態系的意見領袖深度交談，對數位醫療的發展趨勢有第一手的掌握。

戴郁文是美國高通公司業務開發總監，負責「高通台灣創新競賽（Qualcomm Innovate in Taiwan Challenge, QITC）」計畫；佈建合作夥伴關係、並從中開拓新的業務發展機會。QITC自2019年開始舉辦，透過發掘並培育優秀新創團隊，支持台灣新創生態系的成長。

自2007年加入高通之後，戴郁文曾擔任過多個職務，包括在高通CDMA事業部（Qualcomm CDMA Technology, QCT ）客戶工程部門擔任軟體主管；以及在產品行銷部門擔任資深經理，負責關聯性市場 (adjacent market)業務開發，促成產品在設計發想階段就贏得客戶訂單（design wins）及產品上市。加入高通前，戴郁文曾在新創公司及法律事務所擔任研發及專利工程師。

戴郁文擁有國立交通大學電子研究所碩士學位，國立清華大學電機系學士學位，並完成國立台灣大學管理碩士學分班。

張瑞中是 QT Medical 美商宇心生醫的總經理兼任CFO，QT Medical專注於創新的心電圖產品，包括宇心12導心電圖系統與專利貼片。在他豐富的財務經驗之下，他與創辦人同時也是CEO張瑞康醫師，一起成立了QT Medical。

QT Medical讓只能在院內檢查的12導程靜態心電圖走出院外，突破傳統的限制，宇心的12導心電圖系統可大幅節省操作時間、降低傳染風險，同時提供了準確和有效率的檢查流程。QT Medical 讓12導心電圖更普及，並突破時間空間的限制，甚至是病患家中，使醫療人員能夠在任何時間、任何地點透過遠距進行個案管理。在團隊努力下，QT Medical 已經了達成了幾個重要的里程碑，包括隨著取得FDA、TFDA和CE認證與其他認證，也成功導入不同的市場，除了在院內使用，也應用在航空、緊急救護、CRO、運動員篩檢和遠距醫療場域。

Dr. Steven Johnston holds dual roles at Merck KGaA, Darmstadt Germany / EMD Electronics as Vice President and Head of Technology Transformation and Enablement in the Electronics business unit and Vice President and Head of Technology Scouting and Ecosystem Enablement in the Corporate Science and Technology organization. In his Electronics role, he is responsible for leading Merck KGaA’s Electronics engagements internally with Merck KGaA’s Health Care and Life Sciences business units as well as with external partners to enable technology converged and differentiated product development. In addition, he is part of Merck KGaA Electronics leadership team responsible for defining Merck KGaA’s strategic engagement plans with the semiconductor ecosystem. In his corporate Science and Technology organization role, Dr. Johnston heads Merck KGaA’s enabling technology scouting organization that is responsible for identifying and launching disruptive technology and new business growth programs that span the electronics, health care, and life sciences ecosystems and product areas.

Previously Dr. Johnston was at Intel Corporation for 21 years where he was Senior Director of Supplier Technology and Industry Development. In this role, he was responsible for managing Intel’s research and pathfinding supply chain programs with equipment, material, component, and EDA supply chain companies, worldwide consortia engagements, engagements with government funding groups globally for new process technology development, and Intel’s Technology and Manufacturing Group’s strategic market research and PR communication initiatives. Dr. Johnston also oversaw Intel’s technology and manufacturing supply chain IP and collaboration processes and executive alignment of Intel’s silicon technology roadmap with memory and foundry manufacturers. Additionally, Dr. Johnston was responsible for connecting Intel’s technology and manufacturing supply chain roadmap to Semiconductor Industry Association and SEMI global public policy initiatives and other semiconductor industry ecosystem programs.

Dr. Johnston is a member of SEMI’s Board of Industry Leaders, SEMI’s CTO committee, SIA’s CTO committee, and IMEC’s executive advisory council. He also was a founding member of the SIA/SRC Semiconductor Research Vision initiative, chairs the SEMI Industry Strategy Symposium and is an industry advisory board member of the Electron Devices Technology and Manufacturing conference. Dr. Johnston previously served on the SEMATECH and G450C Board of Directors on behalf of Intel Corporation. He has a Ph.D. in Chemical Engineering from the University of Florida, holds 17 patents and has authored ＞60 publications/presentations.